《柳叶刀Gastroenterol Hepatol 2025》修正；9月10日在线发布。https://doi.org/10.1016/s2468 - 1253 (25) 00187 - 6

IF 38.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Lancet Gastroenterology & Hepatology Pub Date : 2025-09-16 DOI:10.1016/s2468-1253(25)00297-3

{"title":"《柳叶刀Gastroenterol Hepatol 2025》修正；9月10日在线发布。https://doi.org/10.1016/s2468 - 1253 (25) 00187 - 6","authors":"","doi":"10.1016/s2468-1253(25)00297-3","DOIUrl":null,"url":null,"abstract":"Torp N, Bech KT, Schnefeld HL, et al Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study. Lancet Gastroenterol Hepatol 2025; published online Sept 10. https://doi.org/10.1016/S2468-1253(25)00187-6—The title of this Article has been corrected. This correction has been made as of Sept 16, 2025.","PeriodicalId":56028,"journal":{"name":"Lancet Gastroenterology & Hepatology","volume":"78 1","pages":""},"PeriodicalIF":38.6000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Gastroenterol Hepatol 2025; published online Sept 10. https://doi.org/10.1016/S2468-1253(25)00187-6\",\"authors\":\"\",\"doi\":\"10.1016/s2468-1253(25)00297-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Torp N, Bech KT, Schnefeld HL, et al Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study. Lancet Gastroenterol Hepatol 2025; published online Sept 10. https://doi.org/10.1016/S2468-1253(25)00187-6—The title of this Article has been corrected. This correction has been made as of Sept 16, 2025.\",\"PeriodicalId\":56028,\"journal\":{\"name\":\"Lancet Gastroenterology & Hepatology\",\"volume\":\"78 1\",\"pages\":\"\"},\"PeriodicalIF\":38.6000,\"publicationDate\":\"2025-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Gastroenterology & Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2468-1253(25)00297-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2468-1253(25)00297-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

Torp N, Bech KT, Schnefeld HL，等。磷脂酰乙醇和自我报告的酒精摄入量对脂肪变性肝病风险个体的亚分类：一项前瞻性队列研究的数据分析。Lancet Gastroenterol Hepatol 2025；9月10日在线发布。https://doi.org/10.1016/S2468-1253(25)00187-6 -本文的标题已被更正。此更正已于2025年9月16日进行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to Lancet Gastroenterol Hepatol 2025; published online Sept 10. https://doi.org/10.1016/S2468-1253(25)00187-6

Torp N, Bech KT, Schnefeld HL, et al Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study. Lancet Gastroenterol Hepatol 2025; published online Sept 10. https://doi.org/10.1016/S2468-1253(25)00187-6—The title of this Article has been corrected. This correction has been made as of Sept 16, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lancet Gastroenterology & Hepatology Medicine-Hepatology

CiteScore

50.30

自引率

1.10%

发文量

期刊介绍： The Lancet Gastroenterology & Hepatology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The Lancet Gastroenterology & Hepatology publishes papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of inflammatory bowel diseases, NAFLD and NASH, functional gastrointestinal disorders, digestive cancers, and viral hepatitis.